Sari Reisner, ScD is Director of Transgender Research and Assistant Professor in the Department of Medicine at Harvard Medical School, based in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women's Hospital, and Assistant Professor in the Department of Epidemiology at Harvard T.H. Chan School of public Health. He is also an Affiliated Research Scientist and Director of the Transgender Health Research Team at The Fenway Institute at Fenway Health.
Trained as a social and psychiatric epidemiologist, his research focuses on: (1) health disparities and inequities in lesbian, gay, bisexual, transgender, queer/ questioning (LGBTQ) populations, with specialization in local, national, and global transgender and gender nonconforming health; (2) the epidemiology of infectious diseases including HIV and sexually transmitted infections (STIs) in marginalized, underserved populations, with focus in biobehavioral intervention design and development; (3) psychiatric epidemiology concentrating on mental health and substance use/abuse risks and resiliencies in adolescents and young adults.
Dr. Reisner is currently an investigator on multiple funded studies in transgender health domestically and internationally, including as PI of a prospective cohort of transgender patients in Boston and New York City funded by the Patient-Centered Outcomes Research Institute (PCORI). He has co-authored more than 150 peer-reviewed journal articles. He was honored as a member of the 2015 Trans100 List—celebrating work “by” and “for” transgender people—in recognition of his contributions in transgender health. Education and Training: Dr. Reisner completed two years of post-doctoral training in Infectious Disease Epidemiology in the Department of Epidemiology at Harvard T.H. School of Public Health. He earned a Doctorate of Science in Society, Human Development, and Health from Harvard T.H. Chan School of Public Health, a Master of Arts from Brandeis University, and a Bachelor of Arts from Georgetown University.